Covered recipient · General Payments record
JENNIFER SCHOFIELD
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,933.23
- Reported across 170 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $529.45 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $155.70 | 13 |
| Novo Nordisk AS | $68.90 | 4 |
| GlaxoSmithKline, LLC. | $63.63 | 4 |
| Exact Sciences Corporation | $44.91 | 3 |
| Lilly USA, LLC | $43.81 | 3 |
| Organon LLC | $32.09 | 1 |
| Acerta Pharma LLC | $31.56 | 2 |
| Phathom Pharmaceuticals, Inc. | $19.72 | 1 |
| EISAI INC. | $19.26 | 1 |
| Amgen Inc. | $18.28 | 1 |
| Merck Sharp & Dohme Corporation | $17.92 | 1 |
| PFIZER INC. | $13.67 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $5.98 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108158821 | CMS |
| ABBVIE INC. | $1.68 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108158823 | CMS |
| ABBVIE INC. | $16.79 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108158825 | CMS |
| ABBVIE INC. | $22.67 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108158827 | CMS |
| ABBVIE INC. | $1.62 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108158829 | CMS |
| ABBVIE INC. | $2.63 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108158831 | CMS |
| ABBVIE INC. | $6.76 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108158833 | CMS |
| ABBVIE INC. | $15.96 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108158835 | CMS |
| ABBVIE INC. | $15.27 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108158837 | CMS |
| ABBVIE INC. | $14.42 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108158839 | CMS |
| ABBVIE INC. | $21.27 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108158841 | CMS |
| ABBVIE INC. | $21.50 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108158843 | CMS |
| ABBVIE INC. | $9.15 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108158845 | CMS |
| Amgen Inc. | $18.28 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117677857 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.27 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105868911 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.29 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104671903 | CMS |
| Eisai Inc. | $19.26 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110804862 | CMS |
| Exact Sciences Corporation | $14.47 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114880257 | CMS |
| Exact Sciences Corporation | $13.36 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114880264 | CMS |
| Exact Sciences Corporation | $17.08 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114880275 | CMS |
| GlaxoSmithKline, LLC. | $16.66 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116643470 | CMS |
| GlaxoSmithKline, LLC. | $14.83 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116662451 | CMS |
| GlaxoSmithKline, LLC. | $14.76 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116472639 | CMS |
| GlaxoSmithKline, LLC. | $17.38 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116209810 | CMS |
| Lilly USA, LLC | $14.41 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135655743 | CMS |
| Lilly USA, LLC | $14.75 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135696458 | CMS |
| Lilly USA, LLC | $14.65 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135710778 | CMS |
| Merck Sharp & Dohme LLC | $17.92 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141984521 | CMS |
| Novo Nordisk Inc | $18.90 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100339838 | CMS |
| Novo Nordisk Inc | $20.29 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100537041 | CMS |
| Novo Nordisk Inc | $14.13 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100354618 | CMS |
| Novo Nordisk Inc | $15.58 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100237242 | CMS |
| Organon Llc | $32.09 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136201265 | CMS |
| PFIZER INC. | $13.67 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131557770 | CMS |
| Phathom Pharmaceuticals, Inc. | $19.72 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151203729 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.